| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2020-02-14 | Opaleye Management Inc. | AVENUE THERAPEUTICS, INC. | 9 | 11.0% | EDGAR |
| SC 13D/A | 2019-04-19 | Fortress Biotech, Inc. | AVENUE THERAPEUTICS, INC. | 3 | 23.3% | EDGAR |
| SC 13D/A | 2019-02-11 | InvaGen Pharmaceuticals, Inc. | AVENUE THERAPEUTICS, INC. | 10,060,512 | 59.9% | EDGAR |
| SC 13G | 2019-01-22 | Opaleye Management Inc. | AVENUE THERAPEUTICS, INC. | 9 | 11.0% | EDGAR |
| SC 13D | 2018-11-23 | InvaGen Pharmaceuticals, Inc. | AVENUE THERAPEUTICS, INC. | 4,227,179 | 38.6% | EDGAR |
| SC 13D | 2017-10-19 | Fortress Biotech, Inc. | AVENUE THERAPEUTICS, INC. | 3,570,425 | 33.1% | EDGAR |